The DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional penetrating corneal transplantation
Open accessAbstract
In the past decade, novel lamellar keratoplasty techniques such as Deep Anterior Lamellar Keratoplasty (DALK) for anterior keratoplasty and Descemet stripping automated endothelial keratoplasty (DSAEK)/Descemet membrane endothelial keratoplasty (DMEK) for posterior keratoplasty have been developed. DALK eliminates the possibility of endothelial allograft rejection, which is the main reason for graft failure after penetrating keratoplasty (PK). Compared to PK, the risk of endothelial graft rejection is significantly reduced after DSAEK/DMEK. Thus, with modern lamellar techniques, the clinical problem of endothelial graft rejection seems to be nearly solved in the low-risk situation. However, even with lamellar grafts there are epithelial, subepithelial and stromal immune reactions in DALK and endothelial immune reactions in DSAEK/DMEK, and not all keratoplasties can be performed in a lamellar fashion. Therefore, endothelial graft rejection in PK is still highly relevant, especially in the "high-risk" setting, where the cornea's (lymph)angiogenic and immune privilege is lost due to severe inflammation and pathological neovascularization. For these eyes, currently available treatment options are still unsatisfactory. In this review, we will describe currently used keratoplasty techniques, namely PK, DALK, DSAEK, and DMEK. We will summarize their indications, provide surgical descriptions, and comment on their complications and outcomes. Furthermore, we will give an overview on corneal transplant immunology. A specific focus will be placed on endothelial graft rejection and we will report on its incidence, clinical presentation, and current/future treatment and prevention options. Finally, we will speculate how the field of keratoplasty and prevention of corneal allograft rejection will develop in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–240 of 240
Prevention of Chronic Renal Allograft Rejection by Soluble CD83
Lan, Z., Lian, D., Liu, W., Arp, J., Charlton, B., Ge, W., Brand, S. R., Healey, D. G., Debenedette, M. A., Nicolette, C. A., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e318200005c · Cited by 42
Yamazoe, K., Yamazoe, K., Yamaguchi, T., Omoto, M., & Shimazaki, J. (2014) · Cornea · doi:10.1097/ico.0000000000000258 · Cited by 42
Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
Hori, J., & Streilein, J. W. (2001) · PubMed · Cited by 41
Topical Ranibizumab inhibits inflammatory corneal hem‐ and lymphangiogenesis
Bucher, F., Parthasarathy, A., Bergua, A., Onderka, J., Regenfuß, B., Cursiefen, C., & Bock, F. (2012) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2012.02525.x · Cited by 41
Self-citationSugino, I. K., Rapista, A., Sun, Q., Wang, J., Nunes, C. F., Cheewatrakoolpong, N., & Zarbin, M. A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8400 · Cited by 41
Ziemssen, F., & Heimann, H. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.701617 · Cited by 41
Amescua, G., Collings, F., Sidani, A., Bonfield, T. L., Rodriguez, J. P., Galor, A., Medina, C. A., Yang, X., & Perez, V. L. (2008) · Transplantation · doi:10.1097/tp.0b013e3181636d9d · Cited by 40
Sano, Y., Br, K., & Jw, S. (2000) · PubMed · Cited by 39
Le, V. N. H., Schneider, A.-C., Scholz, R., Bock, F., & Cursiefen, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-24037-3 · Cited by 39
Self-citationALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions
Willrodt, A., Salabarria, A.-C., Schineis, P., Ignatova, D., Hunter, M. C., Vranova, M., Ochsenbein, A. M., Sigmund, E. C., Romagna, A., Strassberger, V., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00759 · Cited by 39
Self-citationGenetic Heterogeneity of Lymphangiogenesis in Different Mouse Strains
Regenfuß, B., Onderka, J., Bock, F., Hos, D., Maruyama, K., & Cursiefen, C. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090794 · Cited by 38
Self-citationPeppicelli, S., Bianchini, F., & Calorini, L. (2014) · Oncology Letters · doi:10.3892/ol.2014.2297 · Cited by 38
Therapeutic Effects of Topical Netrin-4 Inhibits Corneal Neovascularization in Alkali-Burn Rats
Han, Y., Shao, Y., Liu, T., Qu, Y.-L., Li, W. S., & Liu, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122951 · Cited by 38
Gibbons, A. G., Leung, E. H., & Yoo, S. H. (2018) · Ophthalmology · doi:10.1016/j.ophtha.2018.09.033 · Cited by 37
Elbaz, U., Mireskandari, K., Shen, C., & Ali, A. (2015) · Cornea · doi:10.1097/ico.0000000000000419 · Cited by 36
Fasciani, R., Mosca, L., Giannico, M. I., Ambrogio, S., & Balestrazzi, E. (2014) · International Ophthalmology · doi:10.1007/s10792-014-9938-4 · Cited by 35
Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis
Du, H., Du, L., Tang, X., Ge, H., & Liu, P. (2017) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-017-3651-8 · Cited by 35
Sema3f Protects Against Subretinal Neovascularization In Vivo
Sun, Y., Liegl, R. G.-H., Gong, Y. Q., Bühler, A., Cakir, B., Meng, S. S., Burnim, S. B., Liu, C., Reuer, T., Zhang, P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.03.026 · Cited by 34
Local VEGF-A blockade modulates the microenvironment of the corneal graft bed
Salabarria, A.-C., Braun, G., Heykants, M., Koch, M., Reuten, R., Mahabir, E., Cursiefen, C., & Bock, F. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15331 · Cited by 34
Self-citationThe expression and function of netrin-4 in murine ocular tissues
Li, Y. N., Pinzón‐Duarte, G., Dattilo, M., Claudepierre, T., Koch, M., & Brunken, W. J. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.01.007 · Cited by 33
KINETICS OF LEUKOCYTE AND MYELOID CELL TRAFFIC IN THE MURINE CORNEAL ALLOGRAFT RESPONSE1
Kuffov, L., Lumsden, L., Vesel, V. E., Taylor, J. A., Filipec, M., Hol, V. R., Dick, A. D., & Forrester, J. V. (2001) · Transplantation · doi:10.1097/00007890-200110150-00019 · Cited by 33
Molecular underpinnings of corneal angiogenesis: advances over the past decade
Abdelfattah, N. S., Amgad, M. T., Zayed, A. A., Hussein, H., & El‐Baky, N. A. (2016) · International Journal of Ophthalmology · doi:10.18240/ijo.2016.05.24 · Cited by 32
The good, the bad and the ugly – APCs of the eye
Novak, N., Siepmann, K., Zierhut, M., & Bieber, T. R. M. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.09.009 · Cited by 31
Engagement of CD83 on B Cells Modulates B Cell Function In Vivo
Kretschmer, B., Lüthje, K., Schneider, S., Fleischer, B., & Breloer, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803153 · Cited by 29
Endothelial Mesenchymal Transition: A Therapeutic Target in Retrocorneal Membrane
Miyamoto, T., Sumioka, T., & Saika, S. (2010) · Cornea · doi:10.1097/ico.0b013e3181efe36a · Cited by 29
Role of Angiopoietin-2 in Corneal Lymphangiogenesis
Yuen, D., Grimaldo, S., Sessa, R., Ecoiffier, T., Truong, T. N., Huang, E. C., Bernas, M. J., Daley, S. K., Witte, M. H., & Chen, L. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-13779 · Cited by 28
Systemic cyclosporine and corneal transplantation
Ziaei, M., Ziaei, F., & Manzouri, B. (2015) · International Ophthalmology · doi:10.1007/s10792-015-0137-8 · Cited by 27
Yamada, J., Ueno, M., Toda, M., Shinomiya, K., Sotozono, C., Kinoshita, S., & Hamuro, J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-19020 · Cited by 27
Jitariu, A. A., Cîmpean, A. M., Kundnani, N. R., & Raica, M. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49217 · Cited by 26
MicroRNA-184 Regulates Corneal Lymphangiogenesis
Grimaldo, S., Yuen, D., Theis, J., Ng, M., Ecoiffier, T., & Chen, L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-17733 · Cited by 24
Hos, D., Dörrie, J., Schaft, N., Bock, F., Notara, M., Kruse, F. E., Krautwald, S., Cursiefen, C., & Bachmann, B. O. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.12.004 · Cited by 24
Self-citationMaier, A.-K. B., Klein, S., Kociok, N., et al. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19249 · Cited by 19
Horie, S., Sugita, S., Futagami, Y., Kawaguchi, T., Kamoi, K., Shirato, S., & Mochizuki, M. (2009) · Experimental Eye Research · doi:10.1016/j.exer.2009.01.011 · Cited by 18
Corneal angiogenesis and lymphangiogenesis
Regenfu, B., Bock, F., & Cursiefen, C. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328357b4a2 · Cited by 18
Self-citationWong, H. L. X., Cao, R., Jin, G., Chan, K. M., Cao, Y., & Zhou, Z. (2012) · Cell Cycle · doi:10.4161/cc.20949 · Cited by 17
MiR-199a/b-5p Inhibits Lymphangiogenesis by Targeting Discoidin Domain Receptor 1 in Corneal Injury.
Oh, S., Seo, M., Choi, J., Joo, C., & Lee, S. K. (2018) · PubMed Central · doi:10.14348/molcells.2018.2163 · Cited by 17
Tyrosinase Is a Novel Endogenous Regulator of Developmental and Inflammatory Lymphangiogenesis
Büttner, C., Clahsen, T., Regenfuß, B., Dreisow, M.-L., Steiber, Z., Bock, F., Reis, A., & Cursiefen, C. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.10.014 · Cited by 16
Self-citationIntegrin Alpha 9 Blockade Suppresses Lymphatic Valve Formation and Promotes Transplant Survival
Kang, G. J., Truong, T. N., Huang, E. C., Su, V. L., Ge, S., & Chen, L. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20130 · Cited by 15
Su, C., Chen, C.-W., Ho, W., Hu, F., Lee, S., & Wang, I. (2015) · PubMed Central · Cited by 9
Jeong, H., Yun, J., Lee, D., Lee, E. H., & Cho, C. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27156 · Cited by 9
Metadata
- Authors
- Hos, D., Matthaei, M., Bock, F., Maruyama, K., Notara, M., Clahsen, T., Hou, Y., Le, V. N. H., Salabarria, A.-C., Horstmann, J., Bachmann, B. O., & Cursiefen, C.
- Venue
- Progress in Retinal and Eye Research
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 73
- Pages
- 100768
- ISSN
- 1350-9462 (ISSN-L)
- OpenAlex
- W2955238053
- Cited by
- 303
- References
- 240
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.